Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas

被引:104
作者
Fujisawa, T
Iizasa, T
Saitoh, Y
Sekine, Y
Motohashi, S
Yasukawa, T
Shibuya, K
Hiroshima, K
Ohwada, H
机构
[1] Chiba Univ, Sch Med, Dept Surg, Inst Pulm Canc Res,Chuo Ku, Chiba 2608670, Japan
[2] Chiba Univ, Sch Med, Dept Pathol, Inst Pulm Canc Res,Chuo Ku, Chiba 2608670, Japan
关键词
D O I
10.1200/JCO.1999.17.7.2086
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The majority of lung carcinoma patients requiring resection have smoking habits prior to surgical treatment, and the correlation of smoking with postoperative complications is well known, However, few studies have investigated the correlation between long-term survival and cigarette smoking in patients with primary, resected lung carcinoma. We analyzed the relationship between clinical factors, including cigarette smoking before surgery, and 10-year survival in stage I nan-small-cell lung carcinoma (NSCLC). Patients and Methods: Cigarette smoking habit and other factors influencing either the overall survival or the disease-specific survival rates of patients with stage I primary, resected NSCLC were evaluated according to the Cox proportional hazards model using a total of 369 patients with stage I-NSCLC, Results: Comparison of the cause of death in patients with 30 or more pack-years and patients with less than 30 pack-years showed significant differences in the prevalence of recurrent disease and onset of nonmalignant disease, Multivariate analysis demonstrated significant correlations between overall survival and age and pack-years. Disease-specific survival showed significant correlations with age, tumor classification, and visceral pleural invasion. Conclusion: Smoking pack-years is an important clinical prognostic factor in evaluating overall long-term survival in patients with stage I primary, resected NSCLC. (C) 1999 by American Society of Clinical Oncology.
引用
收藏
页码:2086 / 2091
页数:6
相关论文
共 28 条
[1]  
American Joint Committee on Cancer, 1992, MAN STAG CANC, P115
[2]   CELL-MEDIATED IMMUNE-RESPONSES TO TRANSPLANTED TUMORS IN MICE CHRONICALLY EXPOSED TO CIGARETTE-SMOKE [J].
CHALMER, J ;
HOLT, PG ;
KEAST, D .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (05) :1129-1134
[3]  
COX DR, 1972, J R STAT SOC B, V34, P187
[4]  
DANIELE RP, 1977, AM REV RESPIR DIS, V116, P997
[5]   SMOKING-HABITS OF LONG-TERM SURVIVORS OF SURGERY FOR LUNG-CANCER [J].
DAVISON, G ;
DUFFY, M .
THORAX, 1982, 37 (05) :331-333
[6]   Smoking cessation and lung cancer resection [J].
Dresler, CM ;
Bailey, M ;
Roper, CR ;
Patterson, GA ;
Cooper, JD .
CHEST, 1996, 110 (05) :1199-1202
[7]   SITES OF RECURRENCE IN RESECTED STAGE-I NON-SMALL-CELL LUNG-CANCER - A GUIDE FOR FUTURE STUDIES [J].
FELD, R ;
RUBINSTEIN, LV ;
WEISENBERGER, TH .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (12) :1352-1358
[8]  
GAIL MH, 1984, CANCER, V54, P1802, DOI 10.1002/1097-0142(19841101)54:9<1802::AID-CNCR2820540908>3.0.CO
[9]  
2-4
[10]  
HARPOLE DH, 1995, CANCER RES, V55, P51